1970 B. Sc ( Hons ), Physiology, Calcutta University

1972-73 M. Sc , Physiology, Calcutta University

1979 Ph. D , Biochemistry, Bose Institute, Calcutta University

Research Experience in Cancer Biology- over 35 years in National and International Institutions

Post Doctoral Training              

1980- 83 UGC Research Associate, Bose Institute, Calcutta Univ

1984 Recipient of "Birla International Fellowship"to go to UK

1984-1985 Research Associate, Department of Parmacology,Baylor
College of Medicine, Tx Medical Centre, Houston, USA

Academic Appointments           

1985- 1987 Faculty, Department of Pharmacology, Baylor College of
Medicine, USA

1988-1989 Senior Research Officer, ICMR, CNCI, Calcutta

1990-1991 Facuty, Department of Pharmacology, Baylor College of
Medicine, Houston, USA

1991- 1992 Tumor Biologist, Department of Dermatology, Wellman
Laboratory of Photomedicine, Harvard Medical School,
Boston, USA

1993 -1997 Senior Scientific Officer Gr-1,Head , Department of Receptor Biology and Tumor Metastasis
Chittaranjan National Cancer Institute, Kolkata , India.

1997-2002 Assistant Director Grade/SSO-1

2002- Sr. Assistant Director Grade Scientist/SSO-I

2000 Apr- Jul Visiting Scientist, German Cancer Research Center, DKFZ Heidelberg, Germany

2001 May-Aug Visiting Scientist, DKFZ, Heidelberg, Germany

2002 Apr- June Visiting Scientist, DKFZ, Germany

2007 Feb- March Visiting Scientist DKFZ, Heidelberg, Germany

2007  March 6-10 , Invited Speaker at “ International Conference onTumor Microenvironment” AACR sponsored, Florence, Italy.

2007 July 12 – 14 Expert member and Invited speaker, Indo-German Workshop, 2007, DKFZ, Heidelberg, Germany.

2008 , Apr – May, Invited as “Visiting Professor” to visit Institute Molecular Oncology, IDIBELL,Barcelona, Spain

2016, August- Invited Speaker- International Conference on Drug Delivery, Boston, USA

2018- February- National cancer Conference, Bhubaneswar, Invited Speaker.

2018- March - National Cancer Conference, New Delhi, Invited speaker.

2018- September- Invited Speaker, 2nd world  Cancer Congress, Bangalore and receipient of “ Life Time Achievement Award”.

2019 – August- Invited Speaker- University College of Engineering & Management.

2019- September Invited Speaker & Natinal Committee Member, Indo-Oncology, Bhubaneswar.

International Conference Attended                

American Asson  For  Cancer Research    1985, 1987, 1991,  1992
U I C C   , New Delhi                               1994
U I C C    ,  Sweden                                   1999
Metastasis Research Society, London,UK 2000 (Invited Speaker)
American Asson. Cancer Research, Florence, Italy, March, 2007 (Invited Speaker)

International Conference on Herbal Drugs, New Delhi, Dec, 2006.(Invited Speaker).
International Conference in Human Physiology, Kolkata University,Jan
2007 (Invited Speaker).
2nd Internation Symposium on Translational Research, Lonavala, India,Dec 9-12,2007 (invited Speaker).
Invited speaker at International Conference on Tumor Microenvironment, Florence,Italy March 6-10, 2007.
Invited speaker in Drug Delivery World Congress, Int Conf, Boston, USA, August, 2016
Invited Speaker in PCS Inter Conf, Mumbai, May, 2017
Invited Speaker- Indo-Oncology International Conference, Bhubaneswar,  Feb 2018
Invited Speaker, 2nd world Congress on Oncology, New Delhi, July, 2018

Administrative Experiences :                             

As  Officer-in-Charge (Research unit of C N C I)  and
Several years in the capacity as Head of the Department/ Chairman & Member of different Committees/ National Conferences e t c.

Areas of Research Interest :                            

Integrin biology in relation to tumor development especially metastasis

MMPs biology in relation to cancer / metastasis

Integrin mediated regulation of MMPs expression and function

Integrin receptor mediated signaling

Role of EGFR in cancer biology

In search of anti-metaststic drugs/ compounds.

Tumor  Microenvironment.

Member of the Expert Committees :
(for screening and evaluation of Projects) -                            

Department of Science & Technology, Govt of India
Department of Biotechnology, Govt of India
Indian Council of Medical Research, Govt of India
Council of Scientific & Industrial Research, Govt of India
Academic Advisory Committee (Govt. of West Bengal).

Visiting faculty -  To offer Course Work to P.G students in the Dept, Biophysics,Molecular Biology &  Bioinformatics, Calcuttta  University.
Examinar- St Xaviers College / University

Support from extarnal funding / source              

Project 1 “Role of Integrin Receptor in Cervical Cancer Biology”- DST Funded Project 1997-2001

Project2  “Role of Integrin Receptors in Tumor Metastasis“ CSIR funded Project 1996-2000

Project3 “Role of Integrin and Lectin Molecules in Tumor Metastasis” Indo – German Collaborative Project. 2000-2003

Project 4 “Role of Integrin Receptors in Invasive Potential of Tumor Cells” DST funded Project 2001-2005

Project 5
  “Role of Matrixmetalloproteinases(MMPs) in Tumor Biology “ C S I R   Funded,  2004-2008 

Project 6
“Studies on MMP-2 in Tumor Biology” DRDO. Funded , 2004- 2007

Project 7  “Anti metastatic efficacy of Tea products”--National Tea Research  Foundation, Funded, 2005 -2008. 
Project 8 “Studies on Integrin mediated signaling”-DST funded, 2005-08.

Project  9 "Role of  alfa5beta1 and alfaVbeta3 integrin in regulation of MMPs”- ICMR   Funded,  2007- 2010.

Project 10    Studies on Focal Adhesion Kinase in relation to tumor biology-Funded by DRDO, 2008 - 2011.

project 11  “Studies on MMP-2 in human breast cancer (DST funded, 2009- 2012).

Project 12   Studies on ERK in relaion to breast cancer biology -DST
(DST funded 2011-2014)

Project 13 Studies on fibronectin and its integin in relation to breast cancer biology DST fast Track approved, 2010

Project 14  Anti cancer efficacy of Black Tea Polyphenols- Funded by NTRF ( 2014 – 2017)

Project 15 In search of potential tumor marker – Funded by  DST,  W.B ( 2014 – 2017)

National/ International Membership
1. Member , International Metastasis Research Society,London ., U.K 2. Life Member Indian Asson. For cancer Research

Publications  in International  Journals               78

Ph.D Thesis Awarded/guided  (from jadavpur & Calcutta Universities)- 10

Sanctioned Projects – DST ( New Delhi), ICMR, DRDO, CSIR, NTRF, DST ( West Bengal), W.B, Indo-German etc.


Amitava Chatterjee. 

E mail:


Extra curriculatr activities :           
To get lost in the world of music /  writing poems/  writing articles  /  thinking  abstracts e t c.

Reviewer :           

  1. Carcinogenesis , International Journal, Oxford Press.
  2. Indian Journal of Experimental Biology.
  3. Indian Journal of Medical Research (ICMR)
  4. Journal of Biosciences
  5. International Journal of Cancer Care
  6. European Journal of  Cancer
  7. International Jour of Cancer
  8. Medical  Oncology
  9. Journal of Nutritional Biochemistry
  10. Cancer Research

Original Articles Published in International Journals :           

  1. Chakraborty DP, Chatterjee A Urinary indole profile of B. Melanostictus during hydroquinone induced leucoderma and its regenaration. Clin Chim. Acta 79, 399-400, 1977.
  2. Chakraborty DP, Chowdhury SKR, Dey RN, Chatterjee A Interrelationship of tryptophan pyrrolase in melanogenesis of B. Melanostictus  Clin. Chim Acta 82, 55- 59, 1978.
  3. Chakraborty AK, Chatterjee A, Chakraborty C, Chakraborty DP. Effect of tryptophan on tyrosinase in relation to vitiligo. Experientia 36, 920, 1980
  4. Chakraborty DP, Chatterjee A, Chakraborty AK, Chakraborty C. A method of bioassay of antivitiligo drugs Science and Culture, 47, 228-230.
  5. Chakraborty DP, Chatterjee A, Chakraborty AK Induced depigmentation in B. Melanostictus and ascorbic acid J. Ind. Chem. Soc LVIII, 608-610, 1981.
  6. Chatterjee A, S Ghosh, Das S, Sen S  Isolation of yeast ascospores free of vegetative cell contamination. J. Gen. Microbiol. 128,  2725-2728, 1982.
  7. Chakraborty C, Chatterjee A, Chakraborty AK, Chakraborty DP  Inverse relationship between melanogenesis and endogenous hydroquinone. Experientia 40, 829, 1984.
  8. Freeman JW, Chatterjee A, Busch H  Discrimination of epitope identified by monoclonal antibodies by competitive binding to nitrocellulose bound antigens. J. Immunol. Methods 78, 259- 265, 1985.
  9. Freeman JW,Chatterjee A, Ross B,  Busch H, Epitope discrimination and immunochemical charecterization of nucleolar phosphoprotein C23 using the monoclonal antibodies. Mol. & Cell. Biochem. 68, 87-96, 1985.
  10. Busch H, Busch RK, Chan PK, Chatterjee A,Freeman JW, Ross B, Black A, Yaneva M. Nucleolar antigens in cancer tissues, International Academy of Tumor Marker Oncology, 1, 69-80, 1986.
  11. Chatterjee A, Freeman JW and  Busch H, Development of panel of monoclonal antibodies  against HeLa nuclear and nucleolar antigens associated with cell proliferation. Am. Asson. Cancer Resh. Atlanta,  USA 1987.
  12. Chatterjee A, Freeman JW and Busch H,   Identification and partial charecterisation of a 40 kD nucleolar antigen associated with cell proliferation. Cancer Resh, 47, 1123-1129, 1987.
  13.  Busch H, Freeman JW, Busch RK, Chatterjee A, Black A. At last : meaningful and reproducible immunological distinctions between cancer cells and normal resting cells. Clinical Immunology News Letter 8, 17-20, 1987.
  14. Busch H, Busch RK, Black A, Chan PK, Chatterjee A, Durban E, Freeman JW, Ochs R, Tan EM, Ross B, Yaneva M. Novel nucleolar antigens in autoimmune diseases. J. Reumatol 14, 70-77, 1987.
  15. Chatterjee A, Freeman JW, Busch H Identification and partial charecterisation of a 105, 000 Mr nucleolar antigen associated with cell proliferation. Cancer Resh 47, 6329, 1987.
  16. Busch H, Busch Rk, Chan PK, Chatterjee A, Freeman JW, Ross B, Black A, Yaneva M.  Nucleolar antigens in cancer tissues. Human Tumor markers  Page  203-221,  1987.
  17. Busch H, Busch RK, Freeman JW, Black A, Rabinovsky E, Chatterjee A, Reddy AB, Yaneva M.  Nucleolar G antigens as cancer targets. J. Tumor Marker Oncol. 2, 141-151, 1987.
  18. Chatterjee A, Durban E, Busch H. Charecterisation of a nuclear antigen associated with cell proliferation. Cancer Resh. 48, 7159-7163,  1988.
  19. Reddy AB, Chatterjee A, Rothblum LI, Black A, Busch H. Isolation and charecterisation of a complementary DNA to proliferating cell nucleolar antigen P-40. Cancer Resh. 49, 1763-1767, 1989.
  20. Chatterjee A, Dutta K, Roychowdhury J. Identification of a novel 80 kD antigen associated to cell proliferation. Cancer Letter 47, 199-204, 1989.
  21. Chatterjee A, Busch RK, Zung D, Zahang WW, Busch H, Purification of a group of HeLa nuclear proteins that binds to a proliferating cell nuclear protein P 120 gene. Biochem Biophys Res Commun. 180, 805-815,  1991.
  22. Chatterjee A, Biswas N, Chowdhury S, Roychowdhury J. Idewntification of a 60 kD antigen associated malignant growth of human breast tissue. Oncology 53, 422-425, 1996.
  23.  Chatterjee A. Integrins- New Frontier in Cancer Biology. Ind. Jour. Exp. Resh. 34, 923-926,  1996
  24. Chowdhury SK and Chatterjee A. Reversal of resistance against doxorubicin by a newly developed compound, Oxalibis( N-Phenyl)hydroxamic acid in vitro. Anti Cancer Drug, 9, 825- 832, 1998.
  25. Sengupta S, Ray S, Chattopadhyay N, Biswas N, Chatterjee A. Effect of AllTrans Retinoic acid on metastatic potential of B16F10 cells. J.Exp. Clin. Cancer Resh. 19. No-1, 81-88, 2000.
  26. Ray S, Chattopadhyay N, Biswas N, Chatterjee A. Regulatory moleculas in tumor metastasis. J. Env.Pathol. Toxicol. Oncol 18, No-9, 251-259,1999.
  27. Chattopadhyay N, Ray S, Biswas N, Chatterjee A Effect of All Trans Retinoic Acid  on Integrin receptors of cervical cancer cells(SiHa) Gyn. Oncol 75, 215-221, 1999.
  28. Chattopadhyay N, Chatterjee A. Studies on the expression of alfaVbeta3 integrin receptor in non malignant and malignant human cervical  tumor tissue  J.Exp. Clin. Cancer Resh,20, no-2,269-275,  2001
  29. Chattopadhyay N, Chatterjee A. Role of alfaVbeta3 integrin receptor in the invasive potential of cervical cancer cells. J. Env.Toxicol.Pathol. Oncol 20, no-4,211-221, 2001.
  30. Ray S, Chattopadhyay N, Sanyal U, Biswas N, Chatterjee A. Integrin Modulating Factor: A 30 kD protein that modulates the activity of alfa5beta1 integrin receptor in cervical cancer cells. J. Env. Toxicol. Pathol. Oncol. 20, no-4,199-209 2001.
  31. Sengupta S, Chattopadhyay N, Ray S, Mitra A, Dasgupta S, Chatterjee A. Role of alfaVbeta3 integrin receptor in breast tumor J. Exp. Clin. Cancer Resh. 20,no-4,203-208, 2001
  32. Chattopadhyay N, Mitra A, Frei E , Chatterjee A AlfaVbeta3 Integrin receptor expressed on human cervical cell (SiHa) surface has associated matrixmetalloproteinase activity. J. Cancer Resh. Clin. Oncol,127, 653-658, 2001
  33. Ray S, Chattopadhyay N, Siddiqi M, Mitra A, Chatterjee A Curcumin exhibits antimetastatic properties by modulating Integrin receptors ,collagenase activity, and expression of Nm 23 and E-cadherin. J. Env. Pathol.Toxicol.Oncol. 21, no4, 347-354, 2002                       
  34. Mitra  A, Chakraborty J, Chattopadhyay N, Chatterjee A. Studies on membrane associated MMP2 in human cervical tumor . J.Env.Pathol.Toxicol.Oncol , vol-22, no-2,  2003.
  35. Mitra A,Chakraborty J,Chatterjee A. Ligation of a5b1 integrin by alfa5              monoclonal antibody modulates expression and activity of MMP2 & MMP7          in B16F10  melamona cells . J. Env. Pathol. Toxicol.Oncol, Vol-22 (3), 167-178,  2003.

36.  Banerji. A, Chakraborti, J, Mitra. A, Chatterjee. A Effect of Curcumin on Gelatinase A ( MMP-2) in B16F10 cells  Cancer. Lett.  Vol-211, no-2, 235-242, 2004.
37. Mitra.A, Chakraborti.J, Banerji.A,Chatterjee.A Binding of alfa2 monoclonal antibody to alfa2 beta1 Integrin activates GlatinaseA( MMP2) in human cervical tumor cells( SiHa ) Gynae. Oncol vol-94, no-1, 33-39, 2004.
38. Banerji A, Chakraborti J, Mitra A, Chatterjee A  Cell membrane associated MT1-MMP dependent activation of  proMMP-2 in A375 melanoma cells. Jour. Env. Pathol. Toxicol. Oncol. Vol 24(1), 1-16, 2005.

39. Evelyn Y-L. Kim, Claas Gronewold Amitava Chatterjee,  Claus-    Wilhelm von der Lieth, Christian Kliem, Lutz Langbein, Birgit Schmauser, Manfred Wiessler, Eva Frei. Saccharide mimetics containing galactose and fucose specifically label tumor cell surface and inhibit cell adhesion to fibronectin.  Chem  Bio  Chem, vol-6, 1- 10, 2005.

40. Mitra. A, Chakraborty. J, Banerji. A and  Chatterjee. A Cell Membrane   mediated MT1-MMP dependent activation of Gelatinase A(MMP-2) in human cervical tumor cell(SiHa).     J.Env.Pathol.Toxicol.Oncol , v-25, no-4,655-666, 2006.
41. Chakraborti.J,Mitra.A, Banerji A and Chatterjee.A  Culture of HT-1080 cells in presence of fibronectin activates MMP-2,  Jour.Env.Toxicol.Pathol.Oncol v-25,n0-4,667-677,2006.
42. Mitra A, Chakrabarti J, Bannerji. A, Das S and Chatterjee A   Culture of SiHa cells in presence of fibronectin in serum free culture medium activates MMP-2. Jour. Can. Resh. Clin. Oncol , v-132,505-513,2006.
43. Mitra A, Chakraborti J, Banerji A, Chatterjee A, B R Das   Curcumin a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells  J. Env. Pathol. Toxicol. Oncol.  J.Env.Pathol.Toxicol.Oncol, v-25,n0-4,679-689, 2006.
44. Das  S , Bannerji A, Frei A and  Chatterjee A   Culture of MCF-7 human breast cancer cells in serum free medium in presence of fibronectin activates MMP-2 and MMP-9,  Life  Sciences  vol-82,467-476, 2008
45. Ashok K Chakrabortya, Josane de Frietas Sousa, Debjit Chakraborty, Yoko Funasaka, Mahasweta Bhattacharyaa, Amitava Chatterjee, John Pawelek, GnT-III, a GnT-V Antagonist, Suppresses Melanogenesis  and    Motility in Macrophage-Melanoma Fusion Hybrids,   , GENEv-334, 166-173, 2006
46.Mitra A, Chakraborty J, Bannerji A, Das S, Chatterjee A. Integrin -MMP Interrelation. A potential area to develop anti metastatic drugs-  Treands  in Pharmacology, edited by Roy & Gulati Chapter 26.  2006.
47. Maity G, Mandal S, Chatterjee A, Bhattacharrya D. Purification & Characterization of a low molecular cytotoxic phospholipase A2 from Russel’s viper venom : A multifunctional protein. Jour. Chromato. B,v-845, 232- 243, 2007.
48. Moulik S, Chatterjee A. Vascular endothelial growth factor (VEGF) & tumour angiogenesis. Indian J Med Res 125(6):715-6 (2007) PMID 17704546.
49. Das S, Banerji A, Frei E, Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008 Feb 27;82(9-10):467-76.
50. Moullick S, Sen T, Dutta A, Ghosh C, Bannerji A, Das S,Chatterjee A. Phosphatidylinositol 3-Kinase and NF-κB Involved in Epidermal Growth Factor-Induced Matrix Metalloproteinase-9 Expression. Jour .Cancer Mols. Vol-4(2),55-60, 2008.
51.Banerji A, Chatterjee A. Culture of A-375 cancer cells on fibronectin coated plates activates MMP-2 and MMP-9, Jour. Toxicol. Pathol. Oncol, vol-27(2), 135-145, 2008 .
52. Sen T, Moullick S, Roychowdhury P, Dutta A, Banerji A, Das S, Chatterjee A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sciences vol-84,194-204, 2009.
53.Dutta A, Sen T, Banerji A, Das S, Chatterjee A. Studies on  Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7). Journal of Oncology, Volume 2009,1- 12.
54. Maity G, Fahreen S, Banerji A, Sen T, Dutta A, Roychowdhury P, Chatterjee A. Fn-Integrin mediated signaling in human cervical cancer cells (SiHa), Mol Cell Biochem vol-336,(1-2), 65-74, 2010.
55. Dutta A, Sen T, Chatterjee A. Culture of K562 human myeloid leukemia cells in presence of fibronectin expresses and secretes MMP-9 in serum free culture medium. International Jour of Exp Clin Pathol, vol-3(3), 288-302, 2010
57. Sil H, Sen T, Moulick S, Chatterjee A.  Black Tea Polyphenol (Theafl  avin) Downregu- lates MMP-2 in Human Melanoma Cell Line  A375 by Involving Multiple Regulatory Molecules.  Jour Env Patho toxicol Oncolvol-29(1) 55-68, 2010.
58. Sen T, Dutta A, Maity G, Chatterjee A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie.Volume 92, Issue 10, October 2010, 1422-1434.
59. Sen T, Dutta A, Chatterjee A, EGCG downregulates Gelatinase-B (MMP-9) by involvement of FAK/ERK, NF-kB and AP-I in the human breast cancer cell line MDA-MB-231.  Anti Cancer Drugs vol-21 (6), 632-644, 2010.
60. Dutta A, Sen T, Chatterjee A. All-trans retinoic acid (ATRA) downregulates MMP-9 by modulating its regulatory molecules. Cell Adh Migr. 2010 Jul-Sep; 4(3):409-18.
61. Sen T, Chatterjee A. Epigallocatechin-3-gallate (EGCG) downregulates EGF-induced MMP-9 in breast cancer cells: involvement of integrin receptor α5β1 in the process. Eur J Nutr. 2011 Sep; 50(6):465-78.
62. Maity G, Choudhury P R, Sen T, Ganguly K K, Sil H, Chatterjee A. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2011 Feb; 32(1):129-38.
63. Maity G, Sen T, Chatterjee A. Laminin induces matrix metalloproteinase-9 expression and activation in human cervical cancer cell line (SiHa). J Cancer Res Clin Oncol (2011) 137:347–357.
64. Sil H, Sen T, Chatterjee A. Fibronectin – Integrin (α5β1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9, Oncology Research, vol 19, 2011, 335-348.
65. Pal S, Ganguly K K, Moulik S, Chatterjee A. Modulation of MMPs by cell surface integrin receptor α5β1. (Accepted for publication in Anti-cancer Agents in Medical Chemistry., September, 2011)
66.Ganguly K K, Sen T, Pal S, Biswas J, Chatterjee A. Studies on Focal Adhesion Kinase in Human Breast Cancer cell MDA-MB-231. (Accepted for publication in Advances in Biological Chemistry, Nov, 2011).
67. Ganguly K K, Sen T, Mandal S, Biswas J, Chatterjee A. Studies on Focal Adhesion Kinase in Human Breast Cancer Tissue. (Accepted for publication in Journal of Cancer Therapy, Dec, 2011).
68. Kirat Ganguly, Sekhar Pal, Amitava  Chatterjee,  Integrin and Metastasis, Cell Migration and Adhesion ( Jan 2013).
69. Nanda D,  Sil H, Moulik S, Biswas J andChatterjee A et al, MMP-9 in breast cancerJEPTO ( Oct 2013).
70. Sil H, Moulik S,  Biswas J, Chatterjee A et al  MMP-2 in human breast cancer , Jour of Tumor  (April  2015)
71. Moulik S, Pal S, Biswas J, Amitava  Chatterjee, Role of ERK----------MDA-MB-231, Jour of Tumor, (Jan 2014)
72. Pal S, Moulik S, Dutta A, Chatterjee A, Extracellular matrix protein laminin induces matrix metalloproteinase-9 in human breast cancer cell line MCF-7, Cancer Microenvironment (2014)
73  Sil H and Chatterjee A-  AlfaV beta3- MMP-2  Crosstalk, Jour of Tumor, 2015
74-  Chatterjee  et  al- Effect of Black Tea Polyhenols anonCell-ECM Interaction and MMP- American Journal of Plant Sciences ( March 2017)
75-  Chatterjee  et  al-  Activated Salivary MMP-2- A potential breast cancer marker- Proceedings of Open Conference- Bentham Press, 2017 .
76.  Chatterjee A et al-  Salivary VEGF- a potential Breast cancer marker, Cancer and Clinical Oncology, Vol- 7, N0-2, 2018.
77.  Chatterjee A  et al , Identification  Of Vertebrate MMP-2 and MMP-9 like molecules in the aquous extract of Nasturtium flowers, Bambusa Balcoa leaves and Nayantara flowers ( Jour of Tumor) ( December, 6 (1), 540-544,  2018).
78. Chatterjee  A et al - Identification of a new MMP-2 inhibitor from the aquous extract of Aza Indica leaves ( to be published,  in preparation   September, 2018).


Dr. Amitava Chatterjee. All rights reserved
Site Designed by Bangalinet


My Biographical  Informations My Original Articles Contact Me